Skip to content

SCHEDULE 13D/AAccepted Aug 27, 5:42 PM ET

Inozyme Pharma, Inc. SCHEDULE 13D/A

Pivotal bioVenture Partners Fund I, L.P.

Accepted (ET)

5:42 PM

Aug 27, 2025

Filed

Aug 27, 2025

Documents

1

Size

18.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.